These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 18507151

  • 1. In vitro activity of fluconazole and amphotericin B against Candida inconspicua clinical isolates as determined by the time-kill method.
    Szabó Z, Sóczó G, Miszti C, Hermann P, Rozgonyi F.
    Acta Microbiol Immunol Hung; 2008 Mar; 55(1):53-61. PubMed ID: 18507151
    [Abstract] [Full Text] [Related]

  • 2. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
    Paredes K, Pastor FJ, Capilla J, Sutton DA, Mayayo E, Fothergill AW, Guarro J.
    Rev Iberoam Micol; 2015 Mar; 32(1):34-9. PubMed ID: 24594291
    [Abstract] [Full Text] [Related]

  • 3. In vitro efficacy of amphotericin B, 5-fluorocytosine, fluconazole, voriconazole and posaconazole against Candida dubliniensis isolates using time-kill methodology.
    Szabo Z, Borbely A, Kardos G, Somogyvari F, Kemény-Beke A, Asztalos L, Rozgonyi F, Majoros L.
    Mycoses; 2010 May; 53(3):196-9. PubMed ID: 19761489
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A, Saddi M, Cardia MC, Borgna R, Sanna C, Saddi B, Maccioni E.
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [Abstract] [Full Text] [Related]

  • 5. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM.
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.
    Carrillo-Muñoz AJ, Quindós G, Ruesga M, Alonso R, del Valle O, Hernández-Molina JM, McNicholas P, Loebenberg D, Santos P.
    J Antimicrob Chemother; 2005 Mar; 55(3):317-9. PubMed ID: 15705637
    [Abstract] [Full Text] [Related]

  • 12. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
    Yüksekkaya S, Fındık D, Arslan U.
    Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
    Favel A, Michel-Nguyen A, Datry A, Challier S, Leclerc F, Chastin C, Fallague K, Regli P.
    J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida spp.
    Wardle HM, Law D, Denning DW.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2229-31. PubMed ID: 8878616
    [Abstract] [Full Text] [Related]

  • 18. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA.
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [Abstract] [Full Text] [Related]

  • 19. Determination of minumum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test.
    Birinci A, Saniç A, Durupinar B.
    J Chemother; 2001 Feb; 13(1):43-6. PubMed ID: 11233799
    [Abstract] [Full Text] [Related]

  • 20. Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua.
    Kovács R, Gesztelyi R, Berényi R, Domán M, Kardos G, Juhász B, Majoros L.
    J Med Microbiol; 2014 Feb; 63(Pt 2):186-194. PubMed ID: 24184471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.